This is the first revision of the application by the University of Florida (UF) for a CTSA. The University of Florida (UF) has a rich environment of distinguished colleges, state-of-the-art research facilities and statewide health education and health delivery systems. These resources position UF at the forefront of institutions to train the next generation of clinical and translational investigators and to help overcome two major obstacles in our nation's clinical research enterprise: the translation of basic science discoveries to early investigations in humans and the translation of clinical research into better medical practice and healthcare delivery. UF has made considerable investments dedicated exclusively to accomplish these missions. Furthermore, in direct response to the Clinical and Translational Science Award initiative, it committed substantial new research and training resources and undertook major restructuring of its traditional reporting, research and training operations to create a trans-institutional Clinical and Translational Science Institute (CTSI). The Institute will provide the new intellectual home for clinical and translational research and training at UF, integrating and synergizing the scientific and educational activities of 12 colleges, two academic and clinical campuses, two regional healthcare systems and the 67 counties of the State of Florida. Accordingly, this proposal sets forth the following goals to be accomplished in implementing the Institutional CTSA program;1) Create an environment through which individuals from diverse disciplines can interact, resources, services and technologies can be identified and accessed and local and regional barriers to collaborative research can be overcome;2) Train a workforce of clinical and basic science investigators, clinical trialists, laboratory technicians, study coordinators and other related personnel who are required to establish and support multi- and interdisciplinary clinical and translational research teams3 3) Enhance the quality and availability of cutting-edge technologies and novel research programs to accelerate the discovery, development and application of new diagnostic and therapeutic modalities;and 4) Create new opportunities for clinical scientists and the citizens of Florida to collaborate in advancing education and research into the causes, prevention, diagnosis, treatment and cure of human disease.

Public Health Relevance

The proposal is relevant to the ability of UF to transform the manner by which it conducts multi- and interdisciplinary clinical and translational research and training and by which it engages the citizens across the State of Florida in community-based participatory research, education, health care and health care delivery.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Training Award (TL1)
Project #
5TL1TR000066-05
Application #
8490536
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Program Officer
Brazhnik, Olga
Project Start
2009-07-14
Project End
2014-03-31
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
5
Fiscal Year
2013
Total Cost
$167,926
Indirect Cost
$8,714
Name
University of Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Thompson, Lindsay A; Wegman, Martin; Muller, Keith et al. (2016) Improving Adolescent Health Risk Assessment: A Multi-method Pilot Study. Matern Child Health J 20:2483-2493
Simon, Corey B; Lentz, Trevor A; Bishop, Mark D et al. (2016) Comparative Associations of Working Memory and Pain Catastrophizing With Chronic Low Back Pain Intensity. Phys Ther 96:1049-56
Simon, Corey B; Coronado, Rogelio A; Greenfield 3rd, Warren H et al. (2016) Predicting Pain and Disability After Shoulder Arthroscopy: Rotator Cuff Tear Severity and Concomitant Arthroscopic Procedures. Clin J Pain 32:404-10
Zuo, Jian; Williams, Adrienne E G; Park, Yun-Jong et al. (2016) Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndrome. J Immunol Methods 437:28-36
Aranyos, Alek M; Roff, Shannon R; Pu, Ruiyu et al. (2016) An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection. Vaccine 34:1480-8
Williams, Adrienne E G; Choi, Kevin; Chan, Annie L et al. (2016) Sjögren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFβ signaling. Arthritis Res Ther 18:95
Sacino, Amanda N; Shuster, Jonathan J; Nowicki, Kamil et al. (2016) Novel Application of a Reverse Triage Protocol Providing Increased Access to Care in an Outpatient, Primary Care Clinic Setting. Fam Med 48:136-9
Sukka-Ganesh, B; Larkin 3rd, J (2016) Therapeutic Potential for Targeting the Suppressor of Cytokine Signalling-1 Pathway for the Treatment of SLE. Scand J Immunol 84:299-309
Simon, Corey B; Riley 3rd, Joseph L; Coronado, Rogelio A et al. (2016) Older Age as a Prognostic Factor of Attenuated Pain Recovery After Shoulder Arthroscopy. PM R 8:297-304
Gauna, Adrienne E; Park, Yun-Jong; Nayar, Gautam et al. (2015) Dysregulated co-stimulatory molecule expression in a Sjögren's syndrome mouse model with potential implications by microRNA-146a. Mol Immunol 68:606-16

Showing the most recent 10 out of 21 publications